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Abstract
We conducted active surveillance of acute respiratory viral infections (ARIs) among residents and healthcare personnel (HCP) at a long-term
care facility during the 2015–2016 respiratory illness season. ARIs were observed among both HCP and patients, highlighting the importance
of including HCP in surveillance programs.
(Received 21 March 2019; accepted 2 July 2019; electronically published 25 September 2019)
Respiratory viruses can cause significant morbidity and mortality
in long-term care facilities (LTCFs), whose residents risk signifi-
cant health impacts from these infections.1,2 LTCF residents are
at risk for respiratory infections from living in congregate settings,3
and healthcare personnel (HCP) can play a role in the transmission
of respiratory viruses in LTCFs.
The objective of this study was to conduct active surveillance for
respiratory viral infections among both residents and HCP at
1 LTCF during the 2015–2016 winter respiratory illness season,
using sensitive and broad diagnostic techniques to identify respi-
ratory infections.
Methods
This study was conducted at a 120-bed suburban LTCF provid-
ing both long-term and short-term skilled nursing and rehabili-
tation care. The facility has a mandatory influenza vaccination
policy for staff (97% vaccination rate for the 2014–2015 respi-
ratory illness season), and all patients are offered influenza
vaccination.
All HCP who worked at the facility at any time during the study
period (n= 247) and all patients age ≥18 years with an anticipated
stay of ≥7 days (n= 350) were eligible for participation. We
included long-term residents already living at the facility at the
start of surveillance, as well as new long- and short-term patients
admitted during the surveillance period. Upon enrollment, a mid-
turbinate nasal swab, a throat swab, and a serum specimen were
collected from all study participants. Demographic and clinical
data were collected through interviews, medical record review,
and from facility records.
Active surveillance was conducted between December 2, 2015,
and April 30, 2016. During this period, enrolled HCP and patients
were monitored for acute respiratory illness (ARI) symptoms.
Participants who reported ≥2 of the following symptoms during
the previous 7 days were identified as having an ARI: fever ≥
37.3°C (99.1°F), headache, sore throat, shortness of breath, chills,
muscle and/or joint pain, coughing, wheezing, fatigue, congestion
or runny nose, or change of mental status or confusion. This broad,
symptom-based definition was designed to maximize identifica-
tion of potential respiratory infections. For patients with a medical
condition that might cause chronic respiratory symptoms, symp-
toms were only recorded if they had worsened over the previous
7 days.
Participants with a study-defined ARI had additional nasal and
throat swabs collected at the time of the symptom report and then
weekly for 4 weeks. Serum specimens were collected when an
ARI was identified and at the fourth or final follow-up visit.
Information about symptoms, medical interventions, contact with
sick individuals, and sick days (staff only) were recorded during
these visits.
At the end of the surveillance period, patient discharge or end of
staff employment (whichever came first), final nasal, throat, and
serum specimens were collected, and participants were asked about
respiratory symptoms not previously reported to the study team.
Staff were also asked to report any sick days taken for respiratory
illness.
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All study specimens were tested using a commercial multiplex
real-time reverse-transcriptase polymerase chain reaction (rRT-
PCR) assay kit (FTD Respiratory Pathogens 21, cat. No. FTD-2-
64, Fast-Track Diagnostics, Luxembourg) to detect common
human respiratory viruses.4 Specimens were also tested using
broadly reactive pan virus group (family, subfamily, or genus)
PCRs designed for identification of known, variant, and potentially
novel viruses in a virus group.5 Indirect enzyme immunoassays
(EIAs) for IgG antibodies were performed on serum specimens
following the CDC in-house standard protocols.6
Study data were managed using REDCap electronic data cap-
ture tools hosted at Washington University.7 Data were analyzed
using SPSS Statistics for Windows, version 23.0 software (IBM,
Armonk, NY). Basic enrollment and demographic statistics were
calculated for patients and HCP. The proportion with respiratory
illnesses was calculated using results of the respiratory symptom
assessments and laboratory testing. Reported symptoms were
compared for participants who had positive versus negative study
specimens. The incidence of respiratory illnesses, defined either as
ARI by symptom assessment and/or a study specimen from any
time point that was positive by PCR or serum analysis, was
evaluated to identify potential transmission events.
The study protocol was reviewed and approved by the
Washington University Human Research Protection Office
(HRPO) and the CDC Institutional Review Board. Informed
consent for study participation was obtained from all enrolled
participants or a legally authorized representative.
Results
In total, 76 HCP (31%) were enrolled, including 21 nurses (28%);
10 administrative staff (13%); 9 patient care technicians (12%); 8
food service staff (11%); 8 physical therapists (11%); 7 environ-
mental services staff (9%); 4 occupational therapists (5%); 3 social
workers (4%); 2 recreation therapists (3%); 2 facilities staff (3%);
one dietician (1%); and one speech pathologist (1%). One hundred
and five patients (30%) were enrolled, including 88 (84%) post-
acute care patients and 17 (16%) long-term care patients.
Patient and HCP demographics are described in Table 1.
Thirteen patients (12%) and 24 HCP (32%) reported any respi-
ratory symptoms during the surveillance period, and 4 symptom
reports from patients (31%) and 18 from HCP (75%) met the study
definition forARI.OneHCPhad 2ARIs during surveillance.None of
the patients with ARIs reported contact with a sick visitor during the
previous 5 days; however, 44% of HCP with ARIs reported a sick
household member prior to illness. Of the 18 HCP with an ARI,
5 HCP (28%) reported having taken sick days and 16 (89%) reported
working while ill, including 4 HCP who had also used sick days.
In total, 19 participants (8 patients and 11 HCP, 10%,) had a
positive specimen collected at any point during the study: 18
had a swab specimen positive by PCR and 1 had a positive serum
analysis. Rhinovirus was the most commonly identified pathogen
(Table 1). Of the 18 participants with a positive swab specimen,
9 (50%, 5 patients and 4HCP) never reported respiratory symptoms
and were only identified through laboratory testing. One patient
with a positive swab specimen reported symptoms that did not meet
the case definition for ARI. For all 4 HCP that had positive swab
specimens but no reported symptoms, the positive sample was
collected at enrollment, prior to the start of the surveillance period,
before symptom assessments were being conducted.
Table 1. Patient and Healthcare Personnel (HCP) Demographics
Characteristic
Patients
(N= 105),
No. (%)
HCP
(N= 76)
(%)
Age, y
Mean (SD) 67.6 (11) 43.0 (12)
Median (range) 67 (40–96) 42 (18–65)
Female 66 (63) 60 (79)
Race
White 50 (48) 36 (47)
Black 54 (51) 35 (46)
Hispanic 0 1 (1)
Other/not specified 1 (1) 3 (4)
Received flu vaccination 2015–2016 91 (87) 70 (92)a
Smoking status
Never smoker 52 (50) 49 (65)
Past smoker 48 (46) 19 (25)
Current smoker 5 (5) 6 (8)
Any medical condition(s) with high risk for
respiratory illness or complicationsb
100 (95) 17 (22)
Any contact with children 45 (43) 49 (65)
Positive study specimensc 8 (8) 11 (15)
Rhinovirus 3 (3)d 7 (9)
Influenza A H1N1 2 (2) 1 (1)
Coronavirus 1 (1) 1 (1)
Parainfluenza 0 1 (1)
RSV 2 (2) 0
Adenovirus 0 1 (1)e
Acute respiratory illnessesf 4 (4) 18 (24)
Rhinovirus 1 (1) 3 (4)
Influenza A H1N1 0g 1 (1)
Coronavirus 0 1 (1)
Parainfluenza 0 1 (1)h
RSV 1 (1) 0
Adenovirus 0 0
No virus identified 2 (2) 12 (16)
Note. SD, standard deviation; RSV, respiratory syncytial virus; rRT-PCR, real-time reverse-
transcriptase polymerase chain reaction.
a2 HCP were not vaccinated. One received a medical exemption and the other had an
unknown exemption. Vaccination data were not available for 4 HCP.
bIncludes asthma, chronic obstructive pulmonary disease (COPD), congestive heart failure,
other cardiovascular diseases, diabetes, kidney/renal disease, liver disease, neuromuscular/
neurologic condition, cancer with treatment in the last year, immunosuppressive condition,
pregnancy, dementia, and obesity.
cBased on study specimen testing using rRT-PCR, pan virus group PCR, and serum analysis.
dAn additional patient had a positive clinical specimen collected 1 day after a negative acute
illness study specimen.
eIdentified by serum analysis only.
fIncludes participants with either a positive study specimen or a positive symptom
assessment.
gNeither of the 2 patients with influenza positive specimens had symptom assessment
completed because they were known to have been infected prior to study enrollment. For
1 patient, both the enrollment specimen (collected 11 days after most recent positive clinical
specimen) and the end-of-study specimen (collected 20 days after the enrollment specimen)
were positive for influenza.
hOne HCP had 2 ARIs: 1 with PIV and 1 with negative specimens.
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Among participants who had an ARI, a greater proportion of
individuals with positive versus negative study specimens reported
sore throat (88% vs 64%; P < .05), while a smaller proportion
reported fever (25% vs 43%; P= .57) (Table 2).
Illnesses that occurred during the surveillance period showed
no clear pattern or clustering (Fig. 1). Although respiratory ill-
nesses increased from about mid-February tomid-March, multiple
pathogens were detected (Fig. 1). The timing of this increase in
infections roughly corresponded with the peak in respiratory ill-
nesses in the community (data not shown). Investigation into
the dates, room placement, and specific viruses identified showed
little overlap and a low likelihood of contact between sick HCP and
patients.
Discussion
We conducted active surveillance for respiratory illnesses among
patients and HCP at a single LTCF during the 2015–2016 respira-
tory illness season, using rigorous symptom assessments and spec-
imens collected at multiple time points. Multiple techniques (ie,
PCR, serology, and broadly reactive pan viral group PCR) were
used to identify viral pathogens in study specimens, which
Table 2. Reported Symptoms for Patients and Healthcare Personnel (HCP) who had ARIs With Any Positive Versus All Negative Study
Specimensa
Reported Symptoms
ARI Episodes With a Positive Study Specimen
(N=8), No. (%)
Ari Episodes With Negative Study Specimens
(N=14), No. (%)
Congestion/runny nose 8 (100) 12 (85.7)
Cough 6 (75.0) 11 (78.6)
Sore throat 7 (87.5) 9 (64.3)
Headache 5 (62.5) 7 (50.0)
Fever (≥37.3°C/99.1°F) 2 (25.0) 6 (42.9)
Fatigue 3 (37.5) 9 (64.3)
Muscle or joint pain 3 (37.5) 6 (42.9)
Chills 3 (37.5) 5 (35.7)
Wheezing 2 (25.0) 2 (14.3)
Shortness of breath 3 (37.5) 3 (21.4)
Change in mental status 0 1 (7.1)
Mean age (SD), yb 48.1 (16.7) 46.2 (13.4)
Note. ARI, acute respiratory infection; SD, standard deviation; rRT-PCR, real-time reverse-transcriptase polymerase chain reaction.
arRT-PCR, pan virus group PCR, or serum positive at any point during study enrollment.
b2 HCP with ARIs were missing age data.
Fig. 1. Patients and HCP with acute respiratory
illnesses (ARIs), positive study swab specimens,
or both by study week. Results of positive swabs
are noted above each week. Note. RV, rhinovirus;
RSV, respiratory syncytial virus; Flu, influenza A
H1N1; COV, coronavirus (229e for HCP; OC43
for patients); PIV, parainfluenza 3; Adv, adenovi-
rus. aIn this patient, the enrollment specimen
(collected 11 days after most recent positive
clinical specimen) and the end of study specimen
(collected 20 days after the enrollment speci-
men) were both positive for influenza. Only the
enrollment specimen is shown here. bOne HCP
who had a rise in serum titers for adenovirus is
not included in this figure because the timing
of the infection cannot be determined. cThis
HCP had an ARI but negative study specimens
on April 29. A follow-up study specimen collected
on May 11 was positive for parainfluenza virus 3.
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increased our ability to detect organisms that might be causing res-
piratory illness. Using these sensitive and broad diagnostic meth-
ods, we found fewer infections than anticipated, which might be
related to high influenza vaccination rates at the facility, to good
infection control practices, or to a mild respiratory illness season.
Infection prevention is paramount in healthcare settings to
reduce the risk of infection among individuals.8 In this study pop-
ulation, ARIs and viral detections were less frequent among
patients than among HCP, many of whom had sick contacts out-
side of work. Although there was no evidence for ARI transmission
among study participants, the greater incidence of illnesses among
HCP suggests that paradigms of patient-centered infection preven-
tion programs should expand to include all persons living and
working in an LTCF. In addition, most HCP who had an ARI
worked at the facility while ill, despite a facility policy for ill
HCP to stay home, which is consistent with prior research.9
This finding suggests that facilities should consider strengthening
communication and enforcement of work restriction policies and
should ensure that they are feasible.
Many participants who had a positive study swab collected dur-
ing the surveillance period did not report respiratory symptoms.
Symptom based criteria have been found to be insensitive for iden-
tifying viral infections in hospitalized or older adults.10 The limited
number of symptom reports among patients with positive speci-
mens may also reflect subclinical or asymptomatic presentations,
asymptomatic viral shedding, or a failure to report symptoms to
the study team. HCPmay have been particularly reluctant to report
respiratory symptoms if they had come to work while ill.
This study had several limitations. First, significant staff turn-
over occurred following a change in facility management during
the surveillance period and a wing of the facility was closed to
patients, which decreased the population eligible for study enroll-
ment. Second, some respiratory infections may not have been
detected due to difficulties obtaining paired serology specimens
from early patient discharges, staff turnover, and participants
refusing blood collection. Third, this facility population was a
mix of nursing home residents and shorter-stay posthospital
patients, whichmay affect generalizability to facilities with a differ-
ent patient or resident mix. Finally, this HCP population was
highly vaccinated due to the mandatory influenza vaccination
policy, which likely reduced influenza illness during the 2015–
2016 respiratory illness season, a relatively mild one in St Louis.
Therefore, the results may not be generalizable to LTCFs without
a mandatory influenza vaccination policy or with lower HCP
vaccination rates. Indeed, a previous study by Ursic et al11 reported
higher rates of ARI and viral detections at a nursing home with
lower HCP and patient vaccination rates.11
Despite these limitations, this study demonstrates that active
ARI surveillance can be implemented among both patients and
HCP in an adult LTCF, and that HCP represent a potential source
of ARI transmission in this setting.
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